Latest news : Fifty 1 Labs, Inc.

01-05	Fifty 1 Labs, Inc. Announces CEO Changes	CI
14/08/25	Fifty 1 Labs, Inc. Announces the Completion of the Largest and Most Comprehensive Study of Sickle Cell Disease	CI
10/07/25	Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling 50 1 Labs, Inc. Toward $50 Million Valuation	CI
30/04/25	Fifty 1 Labs, Inc. Appoints Michael Lawson as Chairman of the Board	CI
30/04/25	Fifty 1 Labs, Inc. Appoints Michael Lawson as Chief Executive Officer	CI
30/04/25	The Fifty 1 Labs Biosentry Division Will Develop State-Of-The-Art Biohazard Sensing Sensors Capable of Detecting Pathogens	CI
30/04/25	UAV Corp. Announces Strategic Partnership with 50 1 Labs, Inc	CI
08/04/25	Uav Corp And Genetic Networks Announce Strategic Collaboration	RE
20/03/25	Fifty 1 Labs, Inc. Appoints Gennaro D'Urso as CEO	CI
20/03/25	Fifty 1 Labs, Inc. Appoints Gennaro D'urso as Chairman	CI
19/03/25	Fifty 1 Labs, Inc. acquired Genetic Networks, LLC for $0.02 million.	CI
14/03/25	Consumer Automotive Finance, Inc has Changed its Name to Fifty 1 Labs, Inc	CI
14/03/25	Fifty 1 Labs, Inc. has Changed its Ticker to FITY from CAFI	CI

More news

Press Releases: Fifty 1 Labs, Inc.

07-10	Fifty 1 Labs Announces Strategic Evolution into Peptide Biotechnology and Telehealth	AQ
04-15	Fifty 1 Labs, Inc. Accelerates Peptide Biotechnology Push into Musculoskeletal Health	AQ
04-14	Fifty 1 Labs, Inc. Eliminates 612 Million Shares from the Market	AQ
01-05	Fifty1 Labs, Inc. Clarifies Status Regarding Previously Announced Collaboration with LUNR Aerospace	AQ
09/10/25	Fifty 1 Labs Inc. Appoints Dr. Joel Gagnier as Chief Science Officer	AQ

More press releases

Managers and Directors: Fifty 1 Labs, Inc.

Manager	Title	Age	Since
Pritpaul Singh Arora CEO	Chief Executive Officer	47	-
Brandon Spikes PSD	President	-	-
Alind Gupta CTO	Chief Tech/Sci/R&D Officer	-	-

Director	Title	Age	Since
Robert Clark BRD	Director/Board Member	49	29/04/2025
Brandon Spikes CHM	Chairman	-	11/07/2023
Curtis Young BRD	Director/Board Member	-	-

More insiders

Other Biotechnology & Medical Research

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
FIFTY 1 LABS, INC.	-20.00%	-33.33%	-87.88%	-98.10%	474K
LONZA GROUP AG	-1.40%	+2.59%	-1.71%	+11.28%	48.53B
REVOLUTION MEDICINES, INC.	-2.41%	-0.90%	+403.17%	+614.40%	39.87B
IQVIA HOLDINGS INC.	-1.16%	+12.96%	+26.45%	+5.03%	38.68B
BEONE MEDICINES AG	-1.88%	-3.03%	+4.94%	+47.52%	35.13B
CELLTRION, INC.	-1.74%	+5.12%	+9.58%	+46.02%	29.79B
ASCENDIS PHARMA A/S	-2.85%	-3.92%	-	-	16.08B
MEDPACE HOLDINGS, INC.	-0.21%	-4.04%	+35.09%	+127.95%	16.11B
EUROFINS SCIENTIFIC SE	-0.64%	+2.65%	+1.25%	+8.92%	13.61B
ICON PUBLIC LIMITED COMPANY	-1.19%	-1.32%	-3.32%	-34.94%	12.62B
Average	-3.35%	-2.39%	+43.06%	+80.90%	25.04B
Weighted average by Cap.	-1.60%	+2.03%	+76.87%	+128.10%

See all sector performances

Fifty 1 Labs, Inc. is a Nevada-based holding company focused on health, wellness, and biotech through AI-driven drug repurposing and functional medicine. The Company operates subsidiaries including Fifty1 AI Labs LLC and 51 Labs LLC, which focus on personalized medicine, sports nutrition, and advanced therapeutics. Fifty1 AI Labs LLC delivers transformative solutions for patients and shareholders. 51 Labs LLC offers a line of supplements including pre-workout formulas, BCAAs, ION+ Electrolyte Formula, Turmeric Gummies, and Ashwagandha Gummies designed to enhance athletic performance, recovery, and overall health.

Employees

Sector

Biotechnology & Medical Research

More about the company

Quotes

Date	Price	Change	Volume
31/07/26	US$0.000400	-20.00%	1,864,353
30/07/26	US$0.000500	-.--%	20,764,883
29/07/26	US$0.000500	-.--%	2,070,700
28/07/26	US$0.000500	-16.67%	3,136,300
27/07/26	US$0.000600	-.--%	229,732

Delayed Quote OTC Markets

More quotes

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

Market Cap	281K 245K 228K 209K 395K 26.87M 401K 2.68M 1.05M 13.38M 1.06M 1.03M 44.86M	P/E 2009	-0.05x	P/E 2010	-0.01x
Enterprise Value	12.55M 10.91M 10.16M 9.33M 17.61M 1.2B 17.89M 120M 46.99M 597M 47.15M 46.11M 2B	EV / Sales 2009	1.86x	EV / Sales 2010	2.41x
Free-Float	57.9%	Yield 2009 *	-	Yield 2010	-

1 day	-20.00%
1 week	-33.33%
1 month	-42.86%
6 months	-33.33%
Current year	-20.00%

1 week	0		0
1 month	0		0
Current year	0		0
1 year	0		0
3 years	0		0.05
5 years	0		0.23
10 years	0		0.23

	2009	2010
Net sales	5.41M 4.7M 4.38M 4.02M 7.59M 517M 7.71M 51.61M 20.26M 257M 20.32M 19.88M 862M	5.11M 4.44M 4.13M 3.79M 7.16M 487M 7.27M 48.7M 19.11M 243M 19.18M 18.76M 814M
Net income	-2.23M -1.94M -1.81M -1.66M -3.13M -213M -3.18M -21.28M -8.35M -106M -8.38M -8.2M -356M	-1.89M -1.65M -1.53M -1.41M -2.66M -181M -2.7M -18.07M -7.09M -90.02M -7.11M -6.96M -302M
Net Debt	9.96M 8.65M 8.06M 7.4M 13.97M 950M 14.18M 94.95M 37.27M 473M 37.39M 36.57M 1.59B	12.27M 10.67M 9.93M 9.12M 17.22M 1.17B 17.48M 117M 45.94M 583M 46.09M 45.08M 1.96B

Fifty 1 Labs, Inc. Share Price

Stocks

FITY

US2104931025

Biotechnology & Medical Research

Valuation: Fifty 1 Labs, Inc.

Chart: Fifty 1 Labs, Inc.

Latest news : Fifty 1 Labs, Inc.

Press Releases: Fifty 1 Labs, Inc.

Quotes and Performance

Course Extremes

Managers and Directors: Fifty 1 Labs, Inc.

Other Biotechnology & Medical Research

Financials

Company Profile

Quotes

Market Closed - OTC Markets Other stock markets 20:59:54 31/07/2026 BST			5-day change	1st Jan Change
0.000400 ^USD	-20.00%		-33.33%	-20.00%